Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
129-143
Author(s):
Carl Turesson
Endothelial Chemokines in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
145-154
Author(s):
Kent W. Christopherson II and Robert A. Hromas
Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
155-161
Author(s):
Mae-Xhum Wong and Denise E. Jackson
Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
213-221
Author(s):
Y. S. Lin, C. F. Lin, H. Y. Lei, H. S. Liu, T. M. Yeh, S. H. Chen and C. C. Liu
α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
241-252
Author(s):
Yoshihiro Hayakawa, Dale I. Godfrey and Mark J. Smyth
The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
53-74
Author(s):
Patrick Englebienne
Deaza Analogs of Folic Acid as Antitumor Agents
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2615-2625
Author(s):
R. L. Kisliuk
Naturally Arising CD25+CD4+ Regulatory T Cells in Maintaining Immunologic Self-Tolerance and Preventing Autoimmune Disease
Journal:
Current Molecular Medicine
Volume:
3
Page:
693-706
Author(s):
Takeshi Takahashi and Shimon Sakaguchi
Molecular Mimicry in Autoimmune Neurological Disease after Viral Infection
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1939-1943
Author(s):
Bart O. Roep
Regulation of B-Cell Activation by Complement Receptors CD21 and CD35
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1849-1860
Author(s):
Anna Erdei, Jozsef Prechl, Andrea Isaak and Eszter Molnar